Loading...

Hala Borno, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address550 16th. Street
San Francisco CA 94158
Phone415-476-1528
ORCID ORCID Icon0000-0002-4357-975 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    UCSFFellowship Hematology/Oncology
    UCSFResidency Internal Medicine
    UNC Chapel HillDoctor of MedicineSchool of Medicine
    UNC Chapel HillBachelor of ScienceBiochemistry
    Collapse Awards and Honors
    NIA2017  - 2019T32-AG000212
    Clinical Innovation Center UCSF2017  - 2018Inside Out Accelerator
    UCSF RAP2018  - 2019Integrative Pilot Award
    Prostate Cancer Foundation2018  - 2021Young Investigator Award

    Collapse Overview 
    Collapse Overview
    Dr. Hala Borno is faculty at UCSF and an Assistant Professor in the Department of Medicine and Division of Hematology/Oncology. Dr. Borno is a medical oncologist with clinical expertise in the management of advanced urologic malignancies such as prostate, kidney, bladder, and testicular cancers. She cares for patients at the Helen Diller Family Comprehensive Cancer Center (HDFCCC) at the University of California San Francisco (UCSF). At HDFCCC, Dr. Borno serves on the executive leadership committee for the Prostate Cancer Program and the Liaison to the Office of Community Engagement. She is also a member of the American Society of Clinical Oncology Social Determinants of Health working group, GU committee for NRG oncology, and Health Disparities Committee for Alliance for Clinical Trials in Oncology.

    Dr. Borno's research program consists of prostate cancer therapeutic development and cancer disparities. She serves as medical oncology co-chair for phase III clinical trials and is the principal investigator for clinical trials conducted at HDFCCC in advanced prostate cancer. Dr. Borno has an extensive research program on the promotion of equity in cancer precision medicine.

    She has developed novel recruitment technologies that are clinician and patient facing to promote diversity and inclusion of racial/ethnic minorities in clinical trials. Dr. Borno used human-centered design to develop Trial LibraryTM, a patient facing clinical trial matching tool. Dr. Borno's research has been featured in peer-reviewed journals such JAMA Oncology, Cancer, and Nature. Her work has been covered by national news outlets such as NPR, Washington Post, CBS News, Bloomberg News, and STAT News.

    Dr. Borno graduated with honors in biochemistry and received her medical degree from the University of North Carolina at Chapel Hill where she was a Medical Alumni Loyalty Fund Scholar. She completed her internal medicine residency and medical oncology fellowship training at UCSF. She served as chief oncology fellow at UCSF and was a National Institute on Aging T32 research fellow in the Division of Geriatrics.

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News
    Collapse Twitter
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Differential Treatment Outcomes in BRCA1/2-, CDK12-, and ATM-Mutated Metastatic Castration-Resistant Prostate Cancer. Cancer. 2021 Mar 10. Kwon DH, Chou J, Yip SM, Reimers MA, Zhang L, Wright F, Dhawan MS, Borno HT, Desai A, Aggarwal RR, Wyatt AW, Small EJ, Alva AS, Chi KN, Feng FY, Koshkin VS. PMID: 33690902.
      View in: PubMed   Mentions:    Fields:    
    2. Redefining Attribution From Patient to Health System-How the Notion of "Mistrust" Places Blame on Black Patients. JAMA Oncol. 2021 Mar 04. Borno HT, Andemeskel G, Palmer NR. PMID: 33662096.
      View in: PubMed   Mentions:    Fields:    
    3. Leveraging Social Media as a Thermometer to Gauge Patient and Caregiver Concerns: COVID-19 and Prostate Cancer. European Urology Open Science. 2021 Mar 1; 25:1-4. Stacy Loeb, Rada Mihalcea, Veronica Perez-Rosas, Alex Xu, Jacob Taylor, Nataliya Byrne, Dawn Walter, Marina Ness, Rebecca Robbins, Sylvia Zhang, Trevor Killeen, Divya Natesan, Hala T. Borno. .
      View in: Publisher Site   Mentions:
    4. Examining reporting and representation of patients with cancer in COVID-19 clinical trials. Cancer Rep (Hoboken). 2021 Feb 23; e1355. Rabow M, Wang C, Zhang S, Tahir PM, Small EJ, Borno HT. PMID: 33621447.
      View in: PubMed   Mentions:
    5. Streamlining the genetics pipeline to increase testing for patients at risk for hereditary prostate cancer. Journal of Clinical Oncology. 2021 Feb 20; 39(6_suppl):66-66. Barry Tong, Hala Borno, Fern Alagala, Kelly Gordon, Eric Jay Small, Amy M. Lin, Amie Blanco, Mallika Sachdev Dhawan. .
      View in: Publisher Site   Mentions:
    6. INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy. Journal of Clinical Oncology. 2021 Feb 20; 39(6_suppl):tps179-tps179. Ronald C. Chen, Theodore Karrison, Colleen Anne Lawton, William Adrian Hall, Hala Borno, Mihaela Rosu, Ashesh B. Jani, David M. Schuster, Michael J. Seider, Jason A. Efstathiou, Edwin Melencio Posadas, Paul L. Nguyen, Felix Y Feng. .
      View in: Publisher Site   Mentions:
    7. Androgen deprivation therapy and risk of SARS-CoV-2 infection in men with prostate cancer: A University of California (UC) Health System registry study. Journal of Clinical Oncology. 2021 Feb 20; 39(6_suppl):37-37. Daniel Kwon, Rohit Vashisht, Hala Borno, Rahul Raj Aggarwal, Eric Jay Small, Atul Butte, Franklin W. Huang. .
      View in: Publisher Site   Mentions:
    8. Implementation of clinician-facing prostate cancer therapeutic clinical trial decision tool at a comprehensive cancer center. Journal of Clinical Oncology. 2021 Feb 20; 39(6_suppl):19-19. Hala Borno, Patricia Li, Sylvia Zhang, Dame Idossa, Arpita Desai, Tammy J. Rodvelt, Rohit Bose, Vadim S Koshkin, Jonathon Chou, Terence W. Friedlander, Franklin W. Huang, Eric Jay Small, Rahul Raj Aggarwal. .
      View in: Publisher Site   Mentions:
    9. Assessing the impact of the COVID-19 pandemic on patients with genitourinary malignancies. Journal of Clinical Oncology. 2021 Feb 20; 39(6_suppl):38-38. Hala Borno, Sylvia Zhang, Scarlett Lin Gomez, Celia Kaplan, Christine Miaskowski, Julian Hong, Dame Idossa, Adina Bailey, Eric Jay Small. .
      View in: Publisher Site   Mentions:
    10. Cost-Effectiveness of Immunotherapy Treatments for Renal Cell Carcinoma: A Systematic Review. Kidney Cancer. 2021 Feb 12; 1-16. Errol J. Philip, Sylvia Zhang, Peggy Tahir, Daniel Kim, Francis Wright, Alexander Bell, Hala T. Borno. .
      View in: Publisher Site   Mentions:
    11. Androgen deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry. Ann Oncol. 2021 Jan 29. Kwon DH, Vashisht R, Borno HT, Aggarwal RR, Small EJ, Butte AJ, Huang FW. PMID: 33571636.
      View in: PubMed   Mentions:    Fields:    
    12. Integration of electronic pathology reporting with clinical trial matching for advanced prostate cancer. Urol Oncol. 2021 Jan 05. Borno HT, Duffy C, Zhang S, Canchola AJ, Loya Z, Golden T, Oh DL, Odisho AY, Gomez S. PMID: 33419644.
      View in: PubMed   Mentions:    Fields:    
    13. Policy and Health: Leveraging a Social Determinants of Health Framework to Alleviate the Impact of the COVID-19 Pandemic on Patients With Cancer. JCO Oncol Pract. 2020 Dec 03; OP2000822. Borno HT, Idossa D, Gomez SL. PMID: 33270521.
      View in: PubMed   Mentions:
    14. Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer. Cancer Med. 2020 Nov 28. Borno HT, Kuo Lin T, Odisho AY, Desai A, Koshkin V, Werner K, Legaspi N, Bucknor M, Bell A, Zhang S, Hope TA. PMID: 33247633.
      View in: PubMed   Mentions:    Fields:    
    15. Disparities in precision medicine-Examining germline genetic counseling and testing patterns among men with prostate cancer. Urol Oncol. 2020 Nov 03. Borno HT, Odisho AY, Gunn CM, Pankowska M, Rider JR. PMID: 33158741.
      View in: PubMed   Mentions:    Fields:    
    16. Utilization of a multisite financial reimbursement program to promote racial/ethnic diversity and inclusion in therapeutic cancer clinical trials: The iMPACT Study. Journal of Clinical Oncology. 2020 Oct 10; 38(29_suppl):85-85. Hala Borno, Sylvia Zhang, Elena Nieves, Dana Dornsife, Robert G. Johnson, Darcy V. Spicer. .
      View in: Publisher Site   Mentions:
    17. Disparities in PET imaging for prostate cancer at a tertiary academic medical center. J Nucl Med. 2020 Sep 25. Bucknor MD, Lichtensztajn DY, Lin TK, Borno HT, Gomez SL, Hope TA. PMID: 32978283.
      View in: PubMed   Mentions:    Fields:    
    18. Stress and Symptom Burden in Oncology Patients During the COVID-19 Pandemic. J Pain Symptom Manage. 2020 Nov; 60(5):e25-e34. Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Hammer MJ, Kenfield SA, Kober KM, Levine JD, Pozzar R, Rhoads KF, Van Blarigan EL, Van Loon K. PMID: 32889039.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    19. Oncology patients' perceptions of and experiences with COVID-19. Support Care Cancer. 2021 Apr; 29(4):1941-1950. Miaskowski C, Paul SM, Snowberg K, Abbott M, Borno H, Chang S, Chen LM, Cohen B, Cooper BA, Hammer MJ, Kenfield SA, Laffan A, Levine JD, Pozzar R, Tsai KK, Van Blarigan EL, Van Loon K. PMID: 32809060.
      View in: PubMed   Mentions:    Fields:    
    20. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry. Urol Oncol. 2020 Oct; 38(10):793.e1-793.e11. Borno HT, Cowan JE, Zhao S, Broering JM, Carroll PR, Ryan CJ. PMID: 32782182.
      View in: PubMed   Mentions:    Fields:    
    21. COVID-19 disparities: An urgent call for race reporting and representation in clinical research. Contemp Clin Trials Commun. 2020 Sep; 19:100630. Borno HT, Zhang S, Gomez S. PMID: 32789282.
      View in: PubMed   Mentions:
    22. Determining the impact of Medicaid expansion on cancer burden. Cancer. 2020 Sep 15; 126(18):4114-4117. Borno HT, Lin TK, Batniji RS. PMID: 32627191.
      View in: PubMed   Mentions:    Fields:    
    23. The Ethics of Delivering Precision Medicine-Pretest Counseling and Somatic Genomic Testing. JAMA Oncol. 2020 Jun 01; 6(6):815-816. Borno HT, Rider JR, Gunn CM. PMID: 32163096.
      View in: PubMed   Mentions:    Fields:    
    24. Testicular cancer in Hispanics: incidence of subtypes over time according to neighborhood sociodemographic factors in California. Cancer Causes Control. 2020 Aug; 31(8):713-721. DeRouen MC, McKinley M, Shah SA, Borno HT, Aoki R, Lichtensztajn DY, Leppert JT, Brooks JD, Chung BI, Gomez SL, Cheng I. PMID: 32440828.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. Streamlining the genetics pipeline to increase testing for patients at risk for hereditary prostate cancer. Journal of Clinical Oncology. 2020 May 20; 38(15_suppl):1590-1590. Barry Tong, Hala Borno, Eric Jay Small, Fern Alagala, Amie Blanco, Mallika Sachdev Dhawan. .
      View in: Publisher Site   Mentions:
    26. Sipuleucel-T (sip-T) and oral androgen axis inhibitors in black men being treated for metastatic castration-resistance prostate cancer (mCRPC): Observations from the Medicare Fee for Service (FFS) population. Journal of Clinical Oncology. 2020 May 20; 38(15_suppl):e17589-e17589. Hala Borno, Kelvin A. Moses, Paul Monk, Kate Fitch, Matthew Harmon, Scott Flanders, Rana R. McKay. .
      View in: Publisher Site   Mentions:
    27. Racial disparities and online health information: YouTube and prostate cancer clinical trials. BJU Int. 2020 07; 126(1):11-13. Borno HT, Zhang S, Bakke B, Bell A, Zuniga KB, Li P, Chao K, Sabol A, Killeen T, Hong H, Walter D, Loeb S. PMID: 32275800.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Does the COVID-19 outbreak identify a broader need for an urgent transformation of cancer clinical trials research? Contemp Clin Trials. 2020 05; 92:105997. Borno HT, Small EJ. PMID: 32272172.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCellsPHPublic Health
    29. The limitations of today's clinical guidance: Atypical femoral fracture and long-term bone-modifying agents in the oncology setting. J Oncol Pharm Pract. 2020 Jul; 26(5):1180-1189. Cheung E, Borno HT. PMID: 32122232.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    30. The Problem of Underrepresentation: Black Participants in Lifestyle Trials Among Patients with Prostate Cancer. J Racial Ethn Health Disparities. 2020 Oct; 7(5):996-1002. Zuniga KB, Borno H, Chan JM, Van Blarigan EL, Friedlander TW, Wang S, Zhang L, Kenfield SA. PMID: 32078741.
      View in: PubMed   Mentions:    Fields:    
    31. Efficacy of immune checkpoint inhibitors (ICIs) in rare histological variants of bladder cancer. Journal of Clinical Oncology. 2020 Feb 20; 38(6_suppl):502-502. Errol James Philip, Francis Wright, Daniel Myung Kim, Daniel Kwon, Hansen Ho, Son Ho, Edna Cheung, Emily Chan, Sima P. Porten, Anthony C. Wong, Hala Borno, Arpita Desai, Jonathan Chou, David Yoonsuk Oh, Rahul Raj Aggarwal, Lawrence Fong, Eric Jay Small, Terence W. Friedlander, Vadim S Koshkin. .
      View in: Publisher Site   Mentions:
    32. Disparities in receipt of molecular imaging in biochemical recurrent prostate cancer. Journal of Clinical Oncology. 2020 Feb 20; 38(6_suppl):297-297. Hala Borno, Tracy Kuo Lin, Anobel Y. Odisho, Arpita Desai, Vadim S Koshkin, Kalin Werner, Nichole Legaspi, Alexander Bell, Thomas Hope. .
      View in: Publisher Site   Mentions:
    33. REACT: A feasibility study to test the integration of a cancer registry early case ascertainment process via electronic pathology reporting with an online clinical trial matching tool. Journal of Clinical Oncology. 2020 Feb 20; 38(6_suppl):207-207. Hala Borno, Christine Duffy, Sylvia Zhang, Zinnia Loya, Todd Golden, Debora Oh, Anobel Y. Odisho, Scarlett Lin Gomez. .
      View in: Publisher Site   Mentions:
    34. Treatment outcomes in metastatic prostate cancer patients with DNA damage repair mutations. Journal of Clinical Oncology. 2020 Feb 20; 38(6_suppl):187-187. Daniel Kwon, Francis Wright, Li Zhang, Jonathan Chou, Hala Borno, Arpita Desai, David Yoonsuk Oh, YaoYao Guan Pollock, Rohit Bose, Franklin W. Huang, Thomas Hope, Terence W. Friedlander, Lawrence Fong, Felix Y Feng, Eric Jay Small, Rahul Raj Aggarwal, Vadim S Koshkin. .
      View in: Publisher Site   Mentions:
    35. Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working group. Urol Oncol. 2020 03; 38(3):83-93. Narayan V, Harrison M, Cheng H, Kenfield S, Aggarwal R, Kwon D, McKay R, Hauger R, Hart N, Conzen S, Borno H, Jim H, Dicker A, Dorff T, Moslehi J, Mucci L, Parsons JK, Saad F, Soule H, Morgans A, Ryan CJ. PMID: 31734020.
      View in: PubMed   Mentions:    Fields:    
    36. A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool. Pilot Feasibility Stud. 2019; 5:123. Borno HT, Bakke BM, Kaplan C, Hebig-Prophet A, Chao J, Kim YJ, Yeager J, Cinar P, Small E, Boscardin C, Gonzales R. PMID: 31720002.
      View in: PubMed   Mentions:
    37. How current reporting practices may mask differences: A call for examining cancer-specific demographic enrollment patterns in cancer treatment clinical trials. Contemp Clin Trials Commun. 2019 Dec; 16:100476. Borno HT, Small EJ, Zhang L, DeRouen MC, Griffin A, McGuire J, Ryan CJ, Hiatt RA, Kaplan CP. PMID: 31872154.
      View in: PubMed   Mentions:
    38. Ethnic disparities among men with prostate cancer undergoing germline testing. Urol Oncol. 2020 03; 38(3):80.e1-80.e7. Kwon DH, Borno HT, Cheng HH, Zhou AY, Small EJ. PMID: 31630993.
      View in: PubMed   Mentions: 2     Fields:    
    39. An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study. Pilot Feasibility Stud. 2019; 5:101. Cedars B, Lisker S, Borno HT, Kamal P, Breyer B, Sarkar U. PMID: 31428442.
      View in: PubMed   Mentions:
    40. Tailoring survivorship to diverse populations with genitourinary malignancies. Urol Oncol. 2020 03; 38(3):118-120. Borno HT, Dixit N. PMID: 31307880.
      View in: PubMed   Mentions:    Fields:    
    41. Food insecurity screening: A missing piece in cancer management. Cancer. 2019 Oct 15; 125(20):3494-3501. Patel KG, Borno HT, Seligman HK. PMID: 31287159.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansPHPublic Health
    42. All Men Are Created Equal: Addressing Disparities in Prostate Cancer Care. Am Soc Clin Oncol Educ Book. 2019 Jan; 39:302-308. Borno H, George DJ, Schnipper LE, Cavalli F, Cerny T, Gillessen S. PMID: 31099647.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. Germline Genetic Testing in Advanced Prostate Cancer - Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium. Clinical Genitourinary Cancer. 2019. Channing J. Paller, Emmanuel S. Antonarakis, Tomasz M. Beer, Hala T. Borno, Maria I. Carlo, Daniel J. George, Julie N. Graff, Shilpa Gupta, Elisabeth I. Heath, Celestia S. Higano, Rana R. McKay, Alicia K. Morgans, Akash Patnaik, Daniel P. Petrylak, Matthew B. Rettig, Charles J. Ryan, Mary-Ellen Taplin, Young E. Whang, Jacob Vinson, Heather H. Cheng, Veda N. Giri. View Publication.
    44. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium. Clin Genitourin Cancer. 2019 08; 17(4):275-282.e1. Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson J, Cheng HH, Giri VN. PMID: 31171481.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    45. An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study. Pilot and Feasibility Studies. 2019; 5:101. Benjamin Cedars, Sarah Lisker, Hala T. Borno, Puneet Kamal, Benjamin Breyer, and Urmimala Sarkar.
    46. Differential use of medical versus surgical androgen deprivation therapy for patients with metastatic prostate cancer. Cancer. 2019 02 01; 125(3):453-462. Borno HT, Lichtensztajn DY, Gomez SL, Palmer NR, Ryan CJ. PMID: 30444526.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Apalutamide and its use in the treatment of prostate cancer. Future Oncol. 2019 Feb; 15(6):591-599. Borno HT, Small EJ. PMID: 30426794.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    48. Journal of Clinical Oncology. Implementation of a fellow-initiated financial toxicity screening tool in medical oncology clinics. 2018; 30_suppl(36):64-64. Samuel Craig Brondfield, Hala T. Borno, Claire Mulvey, Li-Wen Huang, Pelin Cinar. View Publication.
    49. A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: Assessing the feasibility, acceptability, and efficacy of a novel recruitment strategy. Contemp Clin Trials Commun. 2018 Dec; 12:60-67. Kaplan CP, Siegel A, Leykin Y, Palmer NR, Borno H, Bielenberg J, Livaudais-Toman J, Ryan C, Small EJ. PMID: 30272035.
      View in: PubMed   Mentions:
    50. Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers. PLoS One. 2018; 13(7):e0199423. Atreya CE, Kubo A, Borno HT, Rosenthal B, Campanella M, Rettger JP, Joseph G, Allen IE, Venook AP, Altschuler A, Dhruva A. PMID: 30036361.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials. Oncologist. 2018 10; 23(10):1242-1249. Borno HT, Zhang L, Siegel A, Chang E, Ryan CJ. PMID: 29700209.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    52. Journal of Clinical Oncology. Minority Equity and Recruitment Into Trials program: Self-assessment of disease-specific cancer clinical trial recruitment patterns at a comprehensive cancer center. 2018; 36(6_suppl ):267-267. Hala T Borno, Joseph P. McGuire, Ann C. Griffin, Charles J. Ryan, Celia Kaplan, Eric Jay Small. View Publication.
    53. Minority Equity and Recruitment Into Trials program: Self-assessment of disease-specific cancer clinical trial recruitment patterns at a comprehensive cancer center. Journal of Clinical Oncology. 2018 Feb 20; 36(6_suppl):267-267. Hala Borno, Joseph P. McGuire, Ann C. Griffin, Charles J. Ryan, Celia Kaplan, Eric Jay Small. .
      View in: Publisher Site   Mentions:
    54. CaPSURE update: Examining primary treatment and survival among men with prostate cancer and bony metastatic disease. Journal of Clinical Oncology. 2018 Feb 20; 36(6_suppl):275-275. Hala Borno, Janet E. Cowan, Shoujun Zhao, Peter Carroll, Charles J. Ryan. .
      View in: Publisher Site   Mentions:
    55. Blood and conflict: managing bleeding disorders in Gaza. East Mediterr Health J. 2018 Jan 02; 23(11):786-787. Borno H. PMID: 29319151.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    56. An unusual manifestation of diabetic ketoacidosis and acute colonic pseudo-obstruction. JRSM Open. 2017 Jun; 8(6):2054270417698632. Natalini J, Borno H, Jin L, Jensen T. PMID: 28620506.
      View in: PubMed   Mentions:
    57. Improving documentation of surrogate decision makers in medical oncology clinic. Journal of Clinical Oncology. 2017 Mar 10; 35(8_suppl):63-63. Melisa L. Wong, Hala Borno, Reena Mahajan, Kara E. Bischoff, Brook Calton, Emily K. Bergsland, Won Kim, Rahul Raj Aggarwal, Katy K. Tsai, Pelin Cinar. .
      View in: Publisher Site   Mentions:
    58. The problem of representativeness of clinical trial participants: understanding the role of hidden costs. J Health Serv Res Policy. 2016 07; 21(3):145-6. Borno H, Siegel A, Ryan C. PMID: 26888478.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    59. Incidence of cleft lip and palate in the palestinian territories: a retrospective study from the Makassed Hospital neonatal unit. Cleft Palate Craniofac J. 2014 Jul; 51(4):472-5. Borno HT, Hussein EA, Dudin A, van Aalst JA. PMID: 23551076.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    60. Cleft Lip and Palate Diagnosis and Management. Birthing and Building Nascent Cleft Teams in Developing Countries. 2012; 871-877. Hussein E, Borno HT, van Aalst JA.
    61. Borno HT, Bakke BM, Kaplan C, Hebig-Prophet A, Chao J, Kim YJ, Yeager J, Cinar P, Small E, Boscardin C, Gonzales R; A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial matching tool.; 2019;5:123.
    Hala's Networks
    Concepts (100)
    Derived automatically from this person's publications.
    _
    Co-Authors (61)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _